Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer

By Gleave M.E.   Coupland D.   Drachenberg D.   Cohen L.   Kwong S.   Goldenberg S.L.   Sullivan L.D.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 708-712

Elsevier

Access to resources Recommend Favorite

Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era

By Gilliland F.D.   Hunt W.C.   Key C.R.  

Urology, Vol. 48, Iss. 1, 1996-07 ,pp. : 67-71

Elsevier

Access to resources Recommend Favorite

Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage - analysis of 136 scans of 100 patients

By Shekarriz B.   Upadhyay J.   Wood D.P.   Hinman J.   Raasch J.   Cummings G.D.   Grignon D.   Littrup P.J.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1044-1048

Elsevier

Access to resources Recommend Favorite

Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant - localization and prediction of tumour volume and grade

By Bassler T.J.   Orozco R.   Bassler I.C.   O'Dowd G.J.   Stamey T.A.  

Urology, Vol. 52, Iss. 6, 1998-12 ,pp. : 1064-1069

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen-producing cells in the bone marrow of a patient with early-stage prostate cancer

By D'Amico A.V.   Matelski H.   O'Leary M.   Sussman B.  

Urology, Vol. 49, Iss. 2, 1997-02 ,pp. : 279-282

Elsevier

Access to resources Recommend Favorite